Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035037.xml
Methods Inf Med 1984; 23(04): 176-182
DOI: 10.1055/s-0038-1635346
DOI: 10.1055/s-0038-1635346
Original Article
Placebo – the Universal Drug
Further Information
Publication History
Publication Date:
20 February 2018 (online)
-
References
- 1 Adler H. M., van Buren Hammelt O.. The doctor-patient relationship revisited. An analysis of the placebo-effect. Ann. intern. Med 1973; 78: 595-598.
- 2 Amery A., de Schaepdryver A.. Antihypertensive therapy in patients above 60. Fifth interim report of the European Working Party on High Blood Pressure in the Elderly (EWPHE). Curr. Concepts Hyper-tens. cardiovasc. Disorders 1981; 2: 14-20.
- 3 Beecher H. K.. The powerful placebo. J. Amer. med. Ass 1955; 159: 1602-1606.
- 4 Beecher H. K.. Evidence for increased effectiveness of placebos with increased stress. Amer. J. Physiol 1956; 187: 163-169.
- 5 Benson H., Epstein M. D.. The placebo effect. A neglected asset in the care of patients. J. Amer. med. Ass 1975; 232: 1225-1227.
- 6 Benson H., McCallie D. P.. Angina pectoris and the placebo effect. New Engl. J. Med 1979; 300: 1424-1429.
- 7 Bok S.. The ethics of giving placebos. Sci. Amer 1974; 231: 17-23.
- 8 Brand J. J., Whittingham P.. Intramuscular hyoscine in control of motion sickness. Lancet 1970; II 232-234.
- 9 Brody H.. Placebos and the philosophy of medicine. Clinical, conceptual and ethical issues. Chicago - London: The University of Chicago Press 1980
- 10 Brody H.. The lie that heals: The ethics of giving placebos. Ann. intern. Med 1982; 97: 112-118.
- 11 Burkhardt R., Kienle G.. Controlled clinical trials and medical ethics. Lancet 1978; II 1356-1359.
- 12 Cleghorn R. A., Graham B. F., Campbell R. B.. et al. Anxiety states: Their response to ACTH and to isotonic saline. Proc. First clin. ACTH Conference, pp 561-565. Philadelphia: Blakiston 1950;
- 13 Dyck W. P., Belsito A., Fleshier B.. et al Cimitidine and placebo in the treatment of benign gastric ulcer. Gut 1977; 20: 730-734.
- 14 Egbert L. D., Battit G. E., Welch C. E.. et al. Reduction of postoperative pain by encouragement and instruction of patients. New Engl. J. Med 1964; 270: 825-827.
- 15 Frost F., Rahbek I., Rune S. J.. et al. Cimetidine in patients with gastric ulcer: a multicentre controlled trial. Brit. med. J 1977; II 795-797.
- 16 Gaddum J. H.. Clinical pharmacology. Proc. roy. Soc. Med 1954; 47: 195-204.
- 17 Gross F.. Notwendigkeit und Ethik klinisch-therapeutischer Prüfungen von Arzneimitteln. (Frankfurt: Paul-Martini-Stiftung der Medizinisch Pharmazeutischen Studiengesellschaft e. V 1979
- 18 Houzak R., Horackova E., Culik A.. Our experience with the effect of placebo in some functional and psychosomatic disorders. Activ. nerv. sup. (Praha) 1972; 14: 184-185.
- 19 Isenberg J. I., Peterson W. L., Elashoff J. D.. et al. Healing of benign gastric ulcer with low-dose antacid or Cimetidinc. A double-blind, randomized, placebo-controlled trial. New Engl. J. Med 1983; 308: 1319-1324.
- 20 Lasagna L., Mosteller F., von Felsinger J. M., Beecher H. K.. A study of the placebo response. Amer. J. Med 1954; 16: 770-779.
- 21 Leslie A.. Ethics and practice of placebo therapy. Amer. J. Med 1954; 16: 854-862.
- 22 Levine J. D., Gordon N. C, Fields H. L.. The mechanism of placebo analgesia. Lancet 1978; II 654-657.
- 23 Management Committee of the Australian Therapeutic Trial in Mild Hypertension Untreated mild hypertension. Lancet 1982; I 185-191.
- 24 Martini P.. Methodenlehre der klinischtherapeutischen Forschung, 3. Aufl. Berlin - Heidelberg - New York: Springer 1953
- 25 Medical Research Council Working Party on Mild to Moderate Hypertension Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Lancet 1981; II 539-543.
- 26 Modell W.. Placebo actions. In Modell W.. (Edit.) Relief of Symptoms. 2nd ed., pp. 47-56. St. Louis: Mosby 1961
- 27 Modell W.. Drugs of Choice. 1970-1971. St. Louis: Mosby 1970;
- 28 Mössinger P.. Der praktische Arzt als Fachmann für Erfahrung und Beobachtung. Neue Denkansätze für die Allgemeinmedizin. Heidelberg: K. F. Haug 1974
- 29 Park L. C, Covi L.. Nonblind placebo trial. An exploration of neurotic outpatients responses to placebo when its inert content is disclosed. Arch. gen. Psychiat 1965; 12: 336-345.
- 30 Raskova H., Elis J.. The role of the placebo in therapeutics. Impact Sci. Soc 1978; 28: 57-65.
- 31 Schaldach H.. (Hrsg.) Wörterbuch der Medizin von Zetkin-Schaldach. 6. Auflage. Stuttgart: Thieme 1978
- 32 Schindel L.. Placebo und Placebo-Effekte in Klinik und Forschung. Arzneimittel-Forsch 1967; 17: 892-918.
- 33 Shapiro A. K.. The placebo response. In Howells J. G.. (Edit.) Modern Perspectives in World Psychiatry, pp. 599-624. Edinburgh: Oliver and Boyd 1968
- 34 Shapiro A. K.. Iatroplacebogenics. Int. Pharmacopsychiat 1969; 2: 215-248.
- 35 Shipley M., Berry H., Broster G.. et al. Controlled trial of homoeopathic treatment of osteoarthritis. Lancet 1983; I 97-98.
- 36 Silber T. J.. Placebo therapy, the ethical dimension. J. Amer. med. Ass 1979; 242: 245-246.
- 37 Vinar O.. Dependence on placebo: A case report. Brit. J. Psychiat 1969; 115: 1189-1190.
- 38 Wolf S.. The pharmacology of placebos. Pharmacol. Rev 1959; 11: 689-704.
- 39 Anonymous The trial of homoeopathy (Editorial). Lancet 1983; I 108.